New York, NY -- (SBWIRE) -- 01/15/2014 -- PennyStockChronicle covers the breadth of the markets, from NASDAQ, NYSE, AMEX, ETF, Penny Stocks, Emerging Markets, activities at the Fed and more. PennyStockChronicle brings you the most vibrant coverage of following stocks: JA Solar Holdings Co., Ltd. (ADR) (NASDAQ:JASO), Merrimack Pharmaceuticals Inc (NASDAQ:MACK), Frontline Ltd (NYSE:FRO), Oxygen Biotherapeutics, Inc (NASDAQ:OXBT)
JA Solar Holdings Co., Ltd. (ADR) (NASDAQ:JASO) showed a volume of 2.68 million shares by the end of last trade whereas the average volume of the stock remained 2.10million shares. The stock opened the session at $9.10 but then moved to $9.19. At that price, the stock showed a positive performance of 2.34%. JA Solar Holdings Co., Ltd. (JA Solar) is engaged in the business of designing, developing, manufacturing and selling solar cell and solar module products. The Company is also engaged in the manufacturing and sales of solar cells. Its principal products are monocrystalline and multicrystalline solar cells and it also manufacture a variety of standard and specialty solar modules.
Will JASO Continue To Move Higher? Find Out Here
Merrimack Pharmaceuticals Inc (NASDAQ:MACK) opened the session at $5.85 and closed the session at $6.28. The stock showed a positive performance of 6.98% in previous trading session. Traded with volume of 2.66 million shares in the prior session and the average volume of the stock remained 2.41 million shares. Merrimack Pharmaceuticals, Inc. is a biopharmaceutical company discovering, developing and preparing to commercialize medicines paired with companion diagnostics for the treatment of serious diseases, with an initial focus on cancer. The Company’s product candidates include MM-398, MM-121, MM-111, MM-302 and MM-151.
For How Long MACK will fight for Profitability? Read This Trend Analysis report
Frontline Ltd (NYSE:FRO) opened the session at $4.60 and closed the session at $4.42. The stock showed a positive performance of 4.60% in previous trading session. The beta of the stock remained 2.05. Frontline Ltd. is a Bermuda-based shipping company engaged primarily in the ownership and operation of oil tanker. The Company operates oil tankers of two sizes: Very Large Crude Carriers (VLCCs), which are between 200,000 and 320,000 deadweight tonnages (dwt),
Why Should Investors Buy FRO After the Recent Fall? Just Go Here and Find Out
Oxygen Biotherapeutics, Inc (NASDAQ:OXBT) the stock decreased -4.18% and finished the session at $6.42. Traded with volume of 2.56 million shares in the prior session and the average volume of the stock remained 1.66 million shares. The beta of the stock remained 0.46. Oxygen Biotherapeutics, Inc. (Oxygen Biotherapeutics) is engaged in the business of developing biotechnology products with a focus on oxygen delivery to tissue. As of April 30, 2011, the Company is developing Oxycyte, a systemic perfluorcarbon (PFC), product.
Will OXBT Get Buyers Even After The Recent Rally? Find Out Here
Penny Stock Chronicle is comprised of a team of vetted penny stock traders who’ve been trading since 2008 & have developed the skills needed to trade for consistent profits.
PLEASE NOTE WELL: The employees of PennyStockChronicle.com are not registered as Investment Advisors in any jurisdiction whatsoever. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. Investing in “penny stocks” is highly speculative.
Verify all claims and do your own due diligence on all securities. PennyStockChronicle.com profiles are not a solicitation or recommendation to buy, sell or hold securities. PennyStockChronicle.com is not offering securities for sale. Neither PennyStockChronicle.com nor its owners, operators, affiliates or anyone disseminating information on its behalf is registered as an Investment Advisor under any federal or state law and none of the information provided by PennyStockChronicle.com, its owners, operators, affiliates or anyone disseminating information on its behalf should be construed as investment advice or investment recommendations. PennyStockChronicle.com does not recommend that the securities profiled should be purchased, sold or held.
Read Full Disclaimer at: http://pennystockchronicle.com/disclaimer
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)